---
title: 'Reply to Kiran Javaid and Cassidy Andruszka: Early disease intervention with
  guselkumab in psoriasis leads to a higher rate of stable complete skin clearance
  (''clinical super response''): Week 28 results from the ongoing phase IIIb randomized,
  double-blind, parallel-group, GUIDE study: An analysis with considerations for future
  studies'
date: '2023-11-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37950571/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231112170907&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...